N. Cowans

发表

First‐trimester ADAM12 and PAPP‐A as markers for intrauterine fetal growth restriction through their roles in the insulin‐like growth factor system

K. Spencer, N. Cowans, 2007, Prenatal diagnosis.

First‐trimester biochemical markers of aneuploidy and the prediction of small‐for‐gestational age fetuses

K. Nicolaides, K. Spencer, K. Nicolaides, 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction

F. Martinez, P. Calverley, D. Niewoehner, 2017, American journal of respiratory and critical care medicine.

Maternal serum CA 19–9 and CA 15–3 levels in pregnancies affected by trisomy 21

K. Spencer, N. Cowans, F. Akinlade, 2012, Prenatal diagnosis.

Adjudication of cardiovascular events in patients with chronic obstructive pulmonary disease: SUMMIT trial

D. Niewoehner, J. Yates, P. Amarenco, 2020, Clinical trials.

FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease

F. Martinez, P. Calverley, R. Brook, 2020, International journal of chronic obstructive pulmonary disease.

Reply to Fisk and Wilkinson: Aortic Pulse Wave Velocity Predicts All-Cause Mortality in Chronic Obstructive Pulmonary Disease

R. Brook, D. Newby, C. Crim, 2020, American journal of respiratory and critical care medicine.

Is maternal renal disease a cause of elevated free β‐hCG in first trimester aneuploidy screening?

K. Spencer, N. Cowans, A. Stamatopoulou, 2009, Prenatal diagnosis.

Correction of first trimester biochemical aneuploidy screening markers for smoking status: influence of gestational age, maternal ethnicity and cigarette dosage

K. Spencer, N. Cowans, Nicholas J. Cowans, 2013, Prenatal diagnosis.

First trimester maternal serum inhibin A concentrations in smokers

K. Spencer, N. Cowans, Nicholas J. Cowans, 2013, Prenatal diagnosis.

First‐trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death

K. Nicolaides, K. Spencer, K. Nicolaides, 2006, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Analytical goal setting in aneuploidy screening: within person biological variability of first trimester biochemical markers

K. Spencer, N. Cowans, Nicholas J. Cowans, 2013, Prenatal diagnosis.

Accuracy of self‐reported smoking status in first trimester aneuploidy screening

K. Spencer, N. Cowans, Nicholas J. Cowans, 2013, Prenatal diagnosis.

First‐trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes

K. Spencer, H. Meiri, N. Cowans, 2008, Prenatal diagnosis.

Cigarette smoking and response to inhaled corticosteroids in COPD

F. Martinez, P. Calverley, R. Brook, 2018, European Respiratory Journal.

Impact of pre-enrolment medication use on clinical outcomes in SUMMIT

P. Calverley, R. Brook, B. Celli, 2019, ERJ Open Research.

Regional differences in rate of FEV1 decline in COPD: lessons from SUMMIT

F. Martinez, P. Calverley, R. Brook, 2019, European Respiratory Journal.

The relationship between maternal body mass, smoking status and ethnicity and first trimester nuchal translucency thickness

K. Spencer, N. Cowans, 2011, Prenatal diagnosis.

Effect of gestational age on first trimester maternal serum prenatal screening correction factors for ethnicity and IVF conception

K. Spencer, N. Cowans, 2013, Prenatal diagnosis.

Placental Protein-13 and Pregnancy-Associated Plasma Protein-A as First Trimester Screening Markers for Hypertensive Disorders and Small for Gestational Age Outcomes

K. Spencer, N. Cowans, C. von Kaisenberg, 2011, Hypertension in pregnancy.

A re‐evaluation of the influence of maternal insulin‐dependent diabetes on fetal nuchal translucency thickness and first‐trimester maternal serum biochemical markers of aneuploidy

K. Spencer, N. Cowans, C. Spencer, 2010, Prenatal diagnosis.

PAPP‐A and free ß‐hCG stability in first trimester serum using PerkinElmer AutoDELFIA® and DELFIA® Xpress systems

K. Spencer, N. Cowans, A. Stamatopoulou, 2010, Prenatal diagnosis.

First-Trimester Biochemical Markers of Aneuploidy and the Prediction of Small-for-Gestational Age Fetuses

K. Nicolaides, K. Spencer, F. Molina, 2009 .

The impact of fetal gender on first trimester nuchal translucency and maternal serum free β‐hCG and PAPP‐A MoM in normal and trisomy 21 pregnancies

K. Nicolaides, K. Spencer, N. Maiz, 2009, Prenatal diagnosis.

The effect of Rhesus status on first‐trimester pregnancy screening markers free β human chorionic gonadotropin, pregnancy‐associated plasma protein‐A and nuchal translucency

K. Spencer, N. Cowans, A. Stamatopoulou, 2009, Prenatal diagnosis.

First trimester intact hCG as an early marker of trisomy 21: a promise unrecognised?

N. Uldbjerg, K. Spencer, N. Tørring, 2008, Prenatal diagnosis.

Maternal serum ADAM12s in the late first trimester of pregnancies with Trisomy 21

K. Spencer, N. Cowans, A. Stamatopoulou, 2008, Prenatal diagnosis.

First‐trimester ADAM12s as early markers of trisomy 21: a promise still unfulfilled?

N. Uldbjerg, K. Spencer, N. Tørring, 2008, Prenatal diagnosis.

Maternal serum ADAM12s as a potential marker of trisomy 21 prior to 10 weeks of gestation

K. Spencer, N. Cowans, A. Vereecken, 2008, Prenatal diagnosis.

Low levels of maternal serum PAPP‐A in the first trimester and the risk of pre‐eclampsia

K. Nicolaides, K. Spencer, N. Cowans, 2008, Prenatal diagnosis.

Maternal serum ADAM12s as a marker of rare aneuploidies in the first or second trimester of pregnancy

K. Spencer, N. Cowans, A. Stamatopoulou, 2007, Prenatal diagnosis.

First‐trimester maternal serum PP‐13, PAPP‐A and second‐trimester uterine artery Doppler pulsatility index as markers of pre‐eclampsia

K. Spencer, H. Meiri, I. Chefetz, 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy

K. Spencer, N. Cowans, 2007, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

Is there an association between maternal ABO and rhesus blood groups and the first‐trimester serum markers free β‐hCG and PAPP‐A used for the detection of fetal aneuploidy?

K. Spencer, N. Cowans, Nicholas J. Cowans, 2007, Prenatal diagnosis.

ADAM 12 as a second‐trimester maternal serum marker in screening for Down syndrome

K. Spencer, S. Larsen, M. Christiansen, 2006, Prenatal diagnosis.

Maternal serum ADAM 12 s as a marker of rare aneuploidies in the first or second trimester of pregnancy

K. Spencer, N. Cowans, A. Stamatopoulou, 2007 .

ADAM 12 as a first‐trimester maternal serum marker in screening for Down syndrome

K. Spencer, S. Larsen, M. Christiansen, 2006, Prenatal diagnosis.

Prediction of pregnancy complications by first‐trimester maternal serum PAPP‐A and free β‐hCG and with second‐trimester uterine artery Doppler

K. Nicolaides, K. Spencer, C. Otigbah, 2005, Prenatal diagnosis.

First and second‐trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels

K. Spencer, N. Cowans, 2005, Prenatal Diagnosis.

Stability of first trimester placental growth factor in serum and whole blood

K. Spencer, H. Alfthan, N. Cowans, 2011, Prenatal diagnosis.

First trimester maternal serum placental growth factor in trisomy 21 pregnancies

K. Spencer, N. Cowans, A. Stamatopoulou, 2010, Prenatal diagnosis.

Second‐trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre‐eclampsia

K. Spencer, H. Meiri, I. Chefetz, 2007, Prenatal diagnosis.

Maternal Serum ADAM-12 as a Potential Marker for Different Adverse Pregnancy Outcomes

K. Spencer, N. Cowans, C. von Kaisenberg, 2010, Fetal Diagnosis and Therapy.

PP13 as a marker of pre-eclampsia: A two platform comparison study.

K. Spencer, A. Khalil, N. Cowans, 2011, Placenta.

Maternal serum inhibin‐A and activin‐A levels in the first trimester of pregnancies developing pre‐eclampsia

K. Spencer, K. Nicolaides, N. Cowans, 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

First‐trimester markers for the prediction of pre‐eclampsia in women with a‐priori high risk

K. Spencer, A. Khalil, H. Meiri, 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

ADAM12s in maternal serum as a potential marker of pre‐eclampsia

K. Spencer, N. Cowans, A. Stamatopoulou, 2008, Prenatal diagnosis.

Maternal plasma levels of follistatin‐related gene protein in the first trimester of pregnancies with Down syndrome

K. Spencer, A. Marcil, Jean Lambert, 2010, Prenatal diagnosis.

First‐trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery

K. Spencer, K. Nicolaides, F. Molina, 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial

F. Martinez, P. Calverley, R. Brook, 2021, ERJ Open Research.

Evaluation of a dried blood spot assay to measure prenatal screening markers pregnancy-associated plasma protein a and free β-subunit of human chorionic gonadotropin.

K. Spencer, N. Cowans, D. Wright, 2013, Clinical chemistry.

Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial

James Brian Byrd, F. Martinez, P. Calverley, 2018, European heart journal.

International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials

P. Calverley, C. Jenkins, B. Celli, 2022, American journal of respiratory and critical care medicine.

Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD

J. Yates, N. Hansel, C. Crim, 2019, Respiratory Research.

First trimester maternal serum placental growth factor levels in twin pregnancies

K. Spencer, N. Cowans, 2013, Prenatal diagnosis.

Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease

F. Martinez, P. Calverley, R. Brook, 2018, Journal of the American College of Cardiology.

Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review

F. Martinez, P. Calverley, B. Celli, 2020, American journal of respiratory and critical care medicine.

First‐trimester placental growth factor as a marker for hypertensive disorders and SGA

K. Spencer, N. Cowans, C. von Kaisenberg, 2010, Prenatal diagnosis.

First trimester maternal serum placental protein 13 for the prediction of pre‐eclampsia in women with a priori high risk

Asma Khalil, K. Spencer, A. Khalil, 2009, Prenatal diagnosis.

The association between gestational diabetes mellitus and first trimester aneuploidy screening markers

K. Spencer, N. Cowans, 2013, Annals of clinical biochemistry.

Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial

V. Kim, F. Martinez, P. Calverley, 2019, BMJ Open Respiratory Research.

Maternal serum placental growth factor in second trimester trisomy 21 pregnancies

K. Spencer, N. Cowans, M. Kisanga, 2012, Prenatal diagnosis.

The stability of free‐β human chorionic gonadotrophin and pregnancy‐associated plasma protein‐A in first trimester dried blood spots

K. Spencer, N. Cowans, A. Stamatopoulou, 2011, Prenatal diagnosis.

A Comparison of Two Immunoassay Methods for the Measurement of Maternal Serum Placental Growth Factor in Early Pregnancy

K. Spencer, N. Cowans, M. Kisanga, 2012, Fetal Diagnosis and Therapy.

Whole blood study Samples were collected from nine voluntary pregnant women during the second to third trimester of pregnancy

K. Spencer, S. Jaakohuhta, N. Cowans, 2010 .

ADAM‐12 stability in first trimester maternal serum

K. Spencer, S. Jaakohuhta, N. Cowans, 2010, Prenatal diagnosis.

The use of serum inhibin A and activin A levels in predicting the outcome of 'pregnancies of unknown location'.

Sabine Van Huffel, Dirk Timmerman, George Condous, 2009, Human reproduction.

Early first‐trimester maternal serum placental growth factor in trisomy 21 pregnancies

K. Spencer, N. Tørring, N. Cowans, 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Pulse Wave Velocity in Chronic Obstructive Pulmonary Disease and the Impact of Inhaled Therapy (SUMMIT): A Randomized Double-blind Clinical Trial.

F. Martinez, P. Calverley, R. Brook, 2020, American journal of respiratory and critical care medicine.

Prediction of pregnancy complications by first‐trimester maternal serum PAPP‐A and free β‐hCG and with second‐trimester uterine artery Doppler

K. Nicolaides, K. Spencer, N. Cowans, 2005, Prenatal diagnosis.

Maternal serum ADAM12s as a potential marker of trisomy 21 prior to 10 weeks of gestation

K. Spencer, N. Cowans, A. Vereecken, 2008, Prenatal diagnosis.

First‐trimester placental growth factor as a marker for hypertensive disorders and SGA

K. Spencer, N. Cowans, A. Stamatopoulou, 2010, Prenatal diagnosis.